Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease

American Journal of Veterinary Research

Volumn 58, Issue 5, 1997, Pages 535-540

  Jensen, JanLee ^a,c   Henik, Rosemary A ^a   Brownfield, Mark ^b   Armstrong, Joel ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c Veterinary Referral Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN II; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; PROPRANOLOL; RENIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; BLOOD PRESSURE; CAT; CAT DISEASE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; MALE; METHODOLOGY; PHYSIOLOGY; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR HYPERTENSION;

ADRENERGIC BETA-ANTAGONISTS; ALDOSTERONE; ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD PRESSURE; CAT DISEASES; CATS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENALAPRIL; FEMALE; HYPERTENSION, RENAL; KIDNEY FAILURE, CHRONIC; MALE; PROPRANOLOL; RADIOIMMUNOASSAY; RENIN; RENIN-ANGIOTENSIN SYSTEM;

EID: 0031137985     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Turner JL, Brogdon JD, Lees GE, et al. Idiopathic hypertension in a cat with secondary hypertensive retinopathy associated with a high-salt diet. J Am Anim Hosp Assoc 1990;26:647-651.
2. Littman MP. Spontaneous systemic hypertension in 24 cats. J Vet Intern Med 1994;8:79-86.
3. Morgan RV. Systemic hypertension in four cats: ocular and medical findings. J Am Anim Hosp Assoc 1986;22:615-621.
4. Stiles J, Polzin DJ, Bistner SI. The prevalence of retinopathy in cats with systemic hypertension and chronic renal failure or hyperthyroidism. J Am Anim Hosp Assoc 1994;30:564-572.
5. Kobayashi DL, Peterson ME, Graves TK, et al. Hypertension in cats with chronic renal failure or hyperthyroidism. J Vet Intern Med 1990;4:58-62.
6. Walker WG. Importance of blood pressure control in the preservation of renal function. South Med J 1994;87:1038-1042.
7. Brazy PC, Stead WW, Fitzwilliam JF. Progression of renal insufficiency: role of blood pressure. Kidney Int 1989;35:670-674.
8. Oldrizzi L, Rugiu C, De Biase V, et al. The place of hypertension among the risk factors for renal function in chronic renal failure. Am J Kidney Dis 1993;21:119-123.
9. Fournier A, el Esper N, Makdassi R, et al. Hypertension and progression of renal insufficiency. Nephrol Dial Transplant 1994;9: 28-34.
10. Williams GH. Biochemical predictors of hypertension. Utility in prevention and treatment. Am J Hypertens 1991;4:629S-632S.
11. Laragh JH. The renin system and new understanding of the complications of hypertension and their treatment. Arzneim-Forsch/Drug Res 1993;43:247-254.
12. DiBartola SP, Rutgers HC, Zack PM, et al. Clinicopathologic findings associated with chronic renal disease in cats: 74 cases (1973-1984). J Am Vet Med Assoc 1987;190:1196-1202.
13. Dow SW, Fettman MJ, LeCouteur RA, et al. Potassium depletion in cats: renal and dietary influences. J Am Vet Med Assoc 1987;191:1569-1575.
14. Dow SW, Fettman MJ, Curtis CR, et al. Hypokalemia in cats: 186 cases (1984-1987). J Am Vet Med Assoc 1989;194:1604-1608.
15. Wilkinson L. Systat: the system for statistics. Evanston, Ill: Systat Inc, 1989.
16. DiBartola SP, Broome MR, Stein BS, et al. Effect of treatment of hyperthyroidism on renal function in cats. J Am Vet Med Assoc 1996;208:875-878.
17. Chew DJ, DiBartola S. Diagnosis and pathophysiology of renal disease. In: Ettinger SJ, ed. Textbook of veterinary internal medicine. Philadelphia: WB Saunders Co, 1989;1893-1962.
18. Smith MC, Dunn MJ. Hypertension due to renal parenchymal disease. In: Brunner B, Rector F, eds. The kidney. Philadelphia WB Saunders Co, 1991;1968-1996.
19. Luke RG, Reig MC. Hypertension. In: Massry SG, Glassrock RJ, eds. Textbook of nephrology. Baltimore: The Williams & Wilkins Co, 1995;1353-1363.
20. Glorioso N, Troffa C, Laragh JH, et al. The cat: an animal model for studies of inactive renin. Am J Physiol 1987;252:E509-E518.
21. Acosta J. Hypertension in chronic renal disease. Kidney Int 1982;22:702-712.
22. Ishii M, Ikeda T, Takagi M, et al. Elevated plasma catecholamines in hypertensives with primary glomerular diseases. Hypertension 1983;5:545-551.
23. Wong SF, Mitchell MI, Robson V, et al. Sodium and renin in the hypertension of early renal disease. Clin Sci Mol Med 1978;4: 301s-303s.
24. Bell PE, Hossack KF, Gabow PA, et al. Hypertension in autosomal dominant polycystic kidney disease. Kidney Int 1988;34: 683-690.
25. Rosenberg ME, Smith LJ, Correa-Rotter R, et al. The paradox of the renin-angiotensin system in chronic renal disease. Kidney Int 1994;45:403-410.
26. Weidmann P, Maxwell MH. The renin-angiotensin-aldosterone system in terminal renal failure. Kidney Int 1975;8:219s-234s.
27. Weidmann P, Maxwell MH, Lupu AN, et al. Plasma renin activity and blood pressure in terminal renal failure. N Engl J Med 1971;285:757-762.
28. Williams GH, Moore TJ, Hollenberg NK. Dysregulation of aldosterone secretion and its relationship to the pathogenesis of essential hypertension. Endocrinol Metab Clin North Am 1991;20:423-447.
29. Laragh JH. Renin profiling for diagnosis, risk assessment, and treatment of hypertension. Kidney Int 1993;44:1163-1175.
30. Laragh JH, Letcher RL, Pickering TG. Renin profiling for diagnoses and treatment of hypertension. JAMA 1979;241:151-156.
31. Brunner HR, Gavras H, Waeber B, et al. Oral angiotensin-converting enzyme inhibitor in long-term treatment of hypertensive patients. Ann Intern Med 1979;90:19-23.
32. Dzau VJ. Implications of local angiotensin production in cardiovascular physiology and pharmacology. Am J Cardiol 1987;59: 59A-65A.
33. Carretero O, Miyazaki S, Scicli AG. Role of kinins in the acute antihypertensive effect of the converting enzyme inhibitor, captopril. Hypertension 1981;3:18-22.
34. Lauler DP. Introduction: aldosterone and spironolactone revisited. Am J Cardiol 1990;65:1K-2K.
35. DiBartola SP, deMorais HSA. Disorders of potassium: hypokalemia and hyperkalemia. In: DiBartola SP, ed. Fluid therapy in small animal practice. Philadelphia: WB Saunders Co, 1992;89-115.
36. Hegstad R, Brown RD, Jiang N-S, et al. Aging and aldosterone. Am J Med 1983;74:442-448.
37. Tsunoda K, Abe K, Toshikazu G, et al. Effect of age on the renin-angiotensin-aldosterone system in normal subjects: simultaneous measurement of active and inactive renin, renin substrate, and aldosterone in plasma. J Clin Endocrinol Metab 1986;62:384-389.
38. Melby JC. Diagnosis of hyperaldosteronism. Endocrin Metab Clin North Am 1991;20:247-255.
39. Williams GH, Hollenberg NK. Functional derangements in the regulation of aldosterone secretion in hypertension. Hypertension 1991;18:III143-III149.
40. Eger CE, Robinson WF, Huxtable CRR. Primary aldosteronism (Conn's syndrome) in a cat; a case report and review of comparative aspects. J Small Anim Pract 1983;24:293-307.
41. Iyori S, Saruta T, Kondo K, et al. Renin and juxtaglomerular apparatus in a patient with primary aldosteronism complicated by chronic renal failure. South Med J 1976;69:951-952.
42. Nakada T, Kimura M. Primary aldosteronism complicated by chronic renal failure. Report of a case. Int Urol Nephrol 1984;16: 165-173.
43. Kurokawa K, Tangiguchi S. Effect of hormones on renal function. In: Massry SG, Glassock RJ, eds. Textbook of nephrology. Baltimore: The Williams & Wilkins Co, 1995;171-181.
44. Koshida H, Miyamori I, Miyazaki R, et al. Falsely elevated plasma aldosterone concentration by direct radioimmunoassay in chronic renal failure. J Lab Clin Med 1989;114:294-300.
45. Henik RA, Snyder PS, Volk LM. Treatment of systemic hypertension in cats with amlodipine besylate. J Am Anim Hosp Assoc 1997;33:In press.